Insights

When the nation is unprepared for catastrophic public health emergencies, the consequences are as real as they can get. As we saw with COVID-19, many people died while the country’s public health app... read more

Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discu... read more

As healthcare organizations consider care at home options, Brianna Motley explains the value of starting with less complex types of care... read more

The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers... read more

You’ve made the effort to align your strategic sourcing and value analysis teams — but are you able to ensure continued success through the sustainability of these changes? Essential components of a ... read more

In his latest blog posting entitled "College Basketball and National Health System Design” Vizient Research Institute executive director Tom Robertson describes an engaging exercise shared with audie... read more

Effective management and preventative maintenance of diagnostic imaging and biomedical equipment can improve patient access to accurate diagnoses and effective treatment while increasing reliability ... read more

Although hospitals have experienced difficult operating periods and volatile stock markets in the past, the simultaneous impact of these two forces in 2022 was a first in not-for-profit healthcare, c... read more